Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 55.55 EUR -0.7% Market Closed
Updated: Mar 25, 2023

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Mar 25, 2023.

Estimated DCF Value of one BAYN stock is 88.03 EUR. Compared to the current market price of 55.55 EUR, the stock is Undervalued by 37%.

BAYN DCF Value
Base Case
88.03 EUR
Undervaluation 37%
DCF Value
Price
Worst Case
Base Case
Best Case
88.03
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 88.03 EUR
Bayer AG Competitors:
DCF Valuation
688356
Jenkem Technology Co Ltd
NVO
Novo Nordisk A/S
3705
YungShin Global Holding Corp
002082
Wanbangde Pharmaceutical Holding Group Co Ltd
REDX
Redx Pharma PLC
300026
Tianjin Chase Sun Pharmaceutical Co Ltd
600993
Mayinglong Pharmaceutical Group Co Ltd
002626
Xiamen Kingdomway Group Co

Present Value Calculation

The first step in the DCF calculation process is to estimate the company's future free cash flow. Once free cash flow is forecasted, it is discounted at a risk-appropriate discount rate. The resulting value is the present value of the company's free cash flow. You can change any model inputs below.

Available Valuation Models
1 valuation model available
Alpha Spread
Updated on Mar 25, 2023
Default Valuation
Create My Valuation Model
Other investors haven't shared any valuation models for Bayer AG.
Model Settings
Discount Rate
6.25%
Forecast Period
5 Years
Terminal Growth
0%
Discount Rate
6.25%
Terminal Growth
0%
Growth Period
5 Years
Copy as My Model

DCF Model
Base Case Scenario

Rotate your device to view
DCF Model

To view the process of deriving the DCF Value of one share from the estimated Present Value, see the DCF Value Calculation block.

DCF Value Calculation

Depending on which type of operating model is chosen (equity or whole firm valuation model), the resulting value is either the value of equity or the value of the entire firm. In the case of the latter, to move from the value of the firm to the value of equity, liabilities are subtracted and assets are added.

Capital Structure
From Present Value to DCF Value

Present Value 109B EUR
+ Cash & Equivalents 5.2B EUR
+ Investments 6.5B EUR
Firm Value 120B EUR
- Debt 33.8B EUR
- Minority Interest 153M EUR
Equity Value 86.5B EUR
/ Shares Outstanding 982M
BAYN DCF Value 88.03 EUR
Undervalued by 37%

To view the process of calculating the Present Value of Bayer AG' future free cash flow, see the Present Value Calculation block.

Valuation Analysis

After the valuation process, in order to gain a deeper understanding of the relationship between risk and opportunity, it is useful to study the dynamic of company's valuation under various inputs to the DCF model in use.

DCF Financials
Financials used in DCF Calculation

Revenue
51.7B 57.5B
Operating Income
9.1B 10.8B
FCFF
7.2B 6.6B

Sensitivity Analysis
DCF Value Sensitivity Analysis

See Also

Similar Stocks
What is the DCF value of one BAYN stock?

Estimated DCF Value of one BAYN stock is 88.03 EUR. Compared to the current market price of 55.55 EUR, the stock is Undervalued by 37%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Using the DCF Operating Model we project Bayer AG's future free cash flow and discount it at a selected discount rate to calculate its Present Value (109B EUR).

2. DCF Value Calculation. We use the company's capital structure to calculate the total Equity Value based on the previously computed Present Value of the free cash flow. Dividing the Equity Value by the number of shares outstanding gives us the DCF Value of 88.03 EUR per one BAYN share.